Inhalation Sciences: Funding, Investors & Team (Oct 2026)
The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a full PK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.
Inhalation Sciences has raised $170k across 2 funding rounds on record, the most recent an undisclosed round of $40k announced in Jun 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Inhalation Sciences Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Inhalation Sciences Funding Rounds
Inhalation Sciences raised $130k in an undisclosed round announced in May 2023.
3.1 years later, an undisclosed round of $40k was announced in Jun 2026.
Inhalation Sciences Founders and Leadership Team
No contact details are on record for this team yet.
Inhalation Sciences Funding Compared to Other Biotechnology Startups
Inhalation Sciences' latest round of $40k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Inhalation Sciences in Biotechnology and Novomirgorod
Companies Similar to Inhalation Sciences
Electronic KYC is a biotechnology company based in Ukraine.
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Inhalation Sciences Funding FAQs
What does Inhalation Sciences do?
The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a full PK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.
How much funding has Inhalation Sciences raised?
Inhalation Sciences has raised $170k across 2 rounds on record. The most recent is an undisclosed round of $40k announced in Jun 2026.
When did Inhalation Sciences last raise funding?
Inhalation Sciences' most recent funding round on record is an undisclosed round of $40k, announced in Jun 2026.
Who founded Inhalation Sciences?
FundedIQ lists Manoush Masarrat (Founder), Per Gerde (Founder) at Inhalation Sciences.
Where is Inhalation Sciences headquartered?
Inhalation Sciences is based in Novomirgorod, Kirovohrads'ka Oblast', Ukraine.
How many employees does Inhalation Sciences have?
Inhalation Sciences is in the 1-10 employee band.
How does Inhalation Sciences' funding compare to other Biotechnology startups?
Inhalation Sciences' latest round of $40k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Inhalation Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Inhalation Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.